ウィスコンシンにおける膠芽腫の臨床試験
ウィスコンシン内の拠点で、膠芽腫に関する8件の研究が参加者を募集しています。
ウィスコンシン内の都市
公式研究テキスト（英語）
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05432804Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
- ThedaCare Regional Cancer Center, Appleton
- University of Wisconsin Carbone Cancer Center - Johnson Creek, Johnson Creek
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- 他6件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/10更新 · NCT07452458A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Froedtert Hospital - Clinical Cancer Center, Milwaukee
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06914128Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06860594SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Wisconsin Health, Madison
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT05303519Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
- Froedtert Menomonee Falls Hospital, Menomonee Falls
- 他3件
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/18更新 · NCT06319027SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Milwaukee
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- University of Wisconsin, Madison
被験者募集中第2相
18歳以上 · 全性別 · 2025/06/27更新 · NCT03175224ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。